The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

The carbon footprint associated with the overuse of short-acting β2-agonists in asthma patients

Background . In recent years, greenhouse gas (GHG) emissions from inhalers have received more attention. The inhalers are classified as controllers and relievers, which are mainly short-acting beta-agonists (SABA), and SABAs account for more than 50% of all inhaler use in most countries. The overuse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Environmental Research Communications 2024-12, Vol.6 (12), p.125009
Hauptverfasser: Chen, Chao-Hsien, Lin, I-Chih, Lai, Chih-Cheng, Liu, Hsing-hui, Wang, Ya-Hui, Wang, Cheng-Yi, Wang, Hao-Chien
Format: Artikel
Sprache:eng
Schlagworte:
Agonists
Asthma
Carbon dioxide
Carbon footprint
Emission analysis
Emissions
Environmental impact
greenhouse gas emissions
Greenhouse gases
Inhalers
SABA
SABA overuse
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background . In recent years, greenhouse gas (GHG) emissions from inhalers have received more attention. The inhalers are classified as controllers and relievers, which are mainly short-acting beta-agonists (SABA), and SABAs account for more than 50% of all inhaler use in most countries. The overuse of SABA is common in asthma patients, but the environmental impact related to these patients has not yet been studied. Methods . Asthma patients were retrieved from Taiwan’s National Health Insurance Database between 2011 and 2020. These patients were classified as SABA overuse (≥3 canisters annually) and controlled (
ISSN:2515-7620
2515-7620
DOI:10.1088/2515-7620/ad9818